HELEN WILSON: Open Payments
NPI 1972108314 · GREENBELT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 15 payments from 12 companies in 2025. Trend: 2023 $712 · 2024 $786 · 2025 $683
Food & beverage: $584Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $113 |
| Phathom Pharmaceuticals, Inc. | 1 | $110 |
| Grifols USA, LLC | 1 | $103 |
| Merck Sharp & Dohme LLC | 2 | $100 |
| Dexcom, Inc. | 1 | $67 |
| Tempus AI, Inc | 2 | $38 |
| Genmab U.S., Inc. | 1 | $32 |
| ARRAY BIOPHARMA INC | 1 | $28 |
| Pharmacosmos Therapeutics Inc. | 1 | $26 |
| Stemline Therapeutics Inc. | 1 | $24 |
Products named: VOQUEZNA, Prolastin-C Liquid, KEYTRUDA, Dexcom G6 Transmitter, XT CDX, Epkinly, LORBRENA, MONOFERRIC.
Industry payments across MD — which companies pay providers there.
